Vis, André N.

Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer

van der Sluis, T. M., Meuleman, E. J. H., van Moorselaar, R. J. A., Bui, H. N., Blankenstein, M. A., Heijboer, A. C., & Vis, A. N. (2012) · BJU International

Prostate Cancer Treatment and ResearchUrinary Bladder and Prostate Research

Cited by 28

Development of a patient decision aid for the treatment of localised prostate cancer: a participatory design approach

Al‐Itejawi, H. H., van Uden‐Kraan, C. F., Vis, A. N., Nieuwenhuijzen, J. A., Hofstee, M. J., van Moorselaar, R. J. A., & Verdonck‐de Leeuw, I. M. (2016) · Journal of Clinical Nursing

Patient-Provider Communication in HealthcareHealth Policy Implementation Science

Cited by 25

Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18 F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer

Jansen, B. H. E., Jansen, R. W., Wondergem, M., Srbljin, S., de Klerk, J. M. H., Lissenberg-Witte, B. I., Vis, A. N., van Moorselaar, R. J. A., Boellaard, R., Hoekstra, O. S., et al. (2020) · Journal of Nuclear Medicine

Medical Imaging Techniques and ApplicationsProstate Cancer Diagnosis and Treatment

Cited by 12